Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genpact (G) Asset Writedowns and Impairment (2016 - 2025)

Genpact (G) has 17 years of Asset Writedowns and Impairment data on record, last reported at -$11.4 million in Q4 2025.

  • For Q4 2025, Asset Writedowns and Impairment rose 7.89% year-over-year to -$11.4 million; the TTM value through Dec 2025 reached $7.7 million, changed N/A, while the annual FY2025 figure was $7.7 million, N/A changed from the prior year.
  • Asset Writedowns and Impairment reached -$11.4 million in Q4 2025 per G's latest filing, down from $710000.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $28.1 million in Q4 2022 and bottomed at -$12.4 million in Q4 2024.
  • Average Asset Writedowns and Impairment over 5 years is $3.4 million, with a median of $743500.0 recorded in 2021.
  • Peak YoY movement for Asset Writedowns and Impairment: surged 3601.05% in 2022, then tumbled 1024.77% in 2024.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $760000.0 in 2021, then soared by 3601.05% to $28.1 million in 2022, then crashed by 103.92% to -$1.1 million in 2023, then crashed by 1024.77% to -$12.4 million in 2024, then rose by 7.89% to -$11.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Asset Writedowns and Impairment were -$11.4 million in Q4 2025, $710000.0 in Q3 2025, and $11.1 million in Q2 2025.